Completed

Evaluation of Hematologic Patients - Training Protocol

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being collected

Data Collection

Who is being recruted

Hemic and Lymphatic Diseases

+ Hematologic Diseases

See all eligibility criteria
How is the trial designed

Observational
Study Start: April 1998
See protocol details

Summary

Principal SponsorNational Institutes of Health Clinical Center (CC)
Last updated: December 16, 2019
Sourced from a government-validated database.Claim as a partner

Study start date: April 21, 1998

Actual date on which the first participant was enrolled.

The Hematology Service provides hematology consultations for patients at the Clinical Center and participates in the training of hematology fellows. Patients with a broad range of hematologic disorders must be available in order for the senior staff of the Service to maintain clinical expertise and to provide the breadth of experience necessary for the fellowship program. The purpose of this protocol is to meet these needs by allowing the Hematology Service to see patients with a spectrum of hematologic diseases not studied on existing research protocols at the NIH. These patients will be evaluated over the course of several outpatient visits and returned to the care of their referring physicians.

NCT00001715
Principal SponsorNational Institutes of Health Clinical Center (CC)
Last updated: December 16, 2019
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

898 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Hemic and Lymphatic DiseasesHematologic Diseases

Criteria

INCLUSION CRITERIA: The patient must have or be suspected of having a blood disorder. The patient must be clinically stable enough for outpatient evaluation. The patients must be referred from a physician outside the NIH who will continue to provide the patient's primary medical care. EXCLUSION CRITERIA: Inability of patient, parent or legal gaurdian to provide informed consent.

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

National Institutes of Health Clinical Center, 9000 Rockville Pike

Bethesda, United StatesOpen National Institutes of Health Clinical Center, 9000 Rockville Pike in Google Maps
CompletedOne Study Center